NorthCoast Asset Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-4,121
Closed -$484K 280
2019
Q1
$484K Sell
4,121
-5,401
-57% -$629K 0.03% 198
2018
Q4
$1.04M Sell
9,522
-982
-9% -$114K 0.08% 139
2018
Q3
$1.34M Sell
10,504
-389
-4% -$48.1K 0.08% 141
2018
Q2
$1.23M Sell
10,893
-413
-4% -$45.4K 0.12% 120
2018
Q1
$1.27M Sell
11,306
-1,160
-9% -$147K 0.12% 120
2017
Q4
$1.84M Sell
12,466
-653
-5% -$83K 0.17% 103
2017
Q3
$1.54M Sell
13,119
-744
-5% -$95K 0.18% 102
2017
Q2
$1.8M Sell
13,863
-1,226
-8% -$153K 0.21% 93
2017
Q1
$2.04M Sell
15,089
-4,439
-23% -$672K 0.19% 85
2016
Q4
$2.8M Sell
19,528
-3,589
-16% -$458K 0.28% 51
2016
Q3
$2.73M Sell
23,117
-15,415
-40% -$1.85M 0.22% 54
2016
Q2
$4.08M Sell
38,532
-1,860
-5% -$207K 0.28% 45
2016
Q1
$4.5M Buy
40,392
+19,040
+89% +$2.41M 0.38% 31
2015
Q4
$3.34M Buy
21,352
+11,687
+121% +$1.7M 0.22% 54
2015
Q3
$1.27M Buy
+9,665
New +$1.55M 0.07% 114
2014
Q3
Sell
-13,008
Closed -$1.15M 169
2014
Q2
$1.15M Buy
+13,008
New +$1.25M 0.07% 102

Other funds holding UTHR

NorthCoast Asset Management's UTHR Position: Q2 2019 in Review

NorthCoast Asset Management sold out of United Therapeutics (UTHR) in Q2 2019, closing a stake of 4,121 shares — an estimated $484K sold.

NorthCoast Asset Management first reported a position in UTHR in Q2 2014 and held it in 16 quarters. The position peaked at $4.5M in Q1 2016. 320 funds tracked by Wall St. Rank hold UTHR as of Q2 2019.

  • NorthCoast Asset Management reported no remaining United Therapeutics position as of Q2 2019 after selling out during the quarter.
  • NorthCoast Asset Management sold 4,121 United Therapeutics shares in Q2 2019, an estimated $484K.
  • NorthCoast Asset Management first reported a position in United Therapeutics in Q2 2014 and held it in 16 quarters.
  • NorthCoast Asset Management's United Therapeutics position peaked at $4.5M in Q1 2016.
  • 320 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2019.

Based on NorthCoast Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.